Table 2.
Characteristic | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
RR | 95 % CI | P | RR | 95 % CI | P | |
Sex | ||||||
Male/female | 0.978 | 0.295–3.733 | 0.972 | |||
Lesion | ||||||
Colon/rectum | 0.697 | 0.201–2.314 | 0.550 | |||
Differentiation | ||||||
tub1, tub2/muc, por | 0.148 | 0.038–0.971 | 0.047* | 0.099 | 0.016–0.765 | 0.030* |
Tumor size | ||||||
≤35 mm/>35 mm | 0.235 | 0.013–1.227 | 0.094 | |||
Depth | ||||||
T1, T2/T3, T4 | <0.0001 | 0.429–0.429 | 0.005* | <0.0001 | 0.269–1.201 | 0.071 |
Lymph node metastasis | ||||||
Negative/positive | 0.179 | 0.039–0.620 | 0.006* | 0.331 | 0.071–1.183 | 0.090 |
Lymphatic permeation | ||||||
Negative/positive | 0.286 | 0.063–0.990 | 0.048* | 0.277 | 0.060–0.978 | 0.046* |
Venous permeation | ||||||
Negative/positive | 0.767 | 0.221–2.547 | 0.661 | |||
miR-132 expression | ||||||
Low/high | 5.01 | 1.290–32.834 | 0.018* | 5.838 | 1.374–42.770 | 0.015* |
RR relative risk, CI confidence interval
* Statistically significant